Biblio

Found 14 results
[ Author(Asc)] Keyword Title Type Year
Filters: Author is Jan B Vermorken  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
J. B. Vermorken, Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG), Int J Gynecol Cancer, vol. 11 Suppl 1, pp. 73-6, 2001.
J. B. Vermorken, Åvall-Lundqvist, E., Pfisterer, J., Bacon, M., ,, -OVAR, A. G. O., ,, -GCC, E. O. R. T. C., ,, ,, ,, ,, ,, -CTG, N. C. I. C., -US, N. C. I., ,, ,, and , The Gynecologic Cancer Intergroup (GCIG): History and current status, Ann Oncol, vol. 16 Suppl 8, pp. viii39-viii42, 2005.
J. B. Vermorken, Parmar, M. K. B., Brady, M. F., Eisenhauer, E., Högberg, T., Ozols, R. F., Rochon, J., Rustin, G. J. S., Sagae, S., Verheijen, R. H. M., InterGroup, G. Cancer, ,, /NCRI, M. R. C., ,, -CTG, N. C. I. C., ,, -OVAR, A. G. O., and , Clinical trials in ovarian carcinoma: study methodology, Ann Oncol, vol. 16 Suppl 8, pp. viii20-viii29, 2005.
J. B. Vermorken, Huinink, W. W. ten Bok, Eisenhauer, E., Favalli, G., Belpomme, D., Conte, P. F., and Kaye, S. B., Advanced ovarian cancer. Carboplatin versus cisplatin., Ann Oncol, vol. 4 Suppl 4, pp. 41-8, 1993.
J. B. Vermorken, The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review., Int J Gynecol Cancer, vol. 3, no. 3, pp. 129-142, 1993.
J. B. Vermorken, Consolidation therapy in patients with advanced ovarian cancer., Eur J Gynaecol Oncol, vol. 15, no. 1, pp. 7-13, 1994.
J. B. Vermorken and Hoekman, K., Chemotherapy for gynecologic malignancies., Curr Opin Oncol, vol. 7, no. 5, pp. 457-65, 1995.
J. B. Vermorken and Pecorelli, S., Clinical trials in patients with epithelial ovarian cancer: past, present and future., Eur J Surg Oncol, vol. 22, no. 5, pp. 455-66, 1996.
J. B. Vermorken, Harper, P. G., and Buyse, M., The role of anthracyclines in epithelial ovarian cancer., Ann Oncol, vol. 10 Suppl 1, pp. 43-50, 1999.
J. B. Vermorken, The role of intraperitoneal chemotherapy in epithelial ovarian cancer., Int J Gynecol Cancer, vol. 10, no. S1, pp. 26-32, 2000.
J. B. Vermorken, Optimal treatment for ovarian cancer: taxoids and beyond., Ann Oncol, vol. 11 Suppl 3, pp. 131-9, 2000.
J. B. Vermorken, Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG)., Int J Gynecol Cancer, vol. 11 Suppl 1, pp. 73-6, 2001.
J. B. Vermorken, Parmar, M. K. B., Brady, M. F., Eisenhauer, E., Högberg, T., Ozols, R. F., Rochon, J., Rustin, G. J. S., Sagae, S., and Verheijen, R. H. M., Clinical trials in ovarian carcinoma: study methodology., Ann Oncol, vol. 16 Suppl 8, pp. viii20-viii29, 2005.
J. B. Vermorken, Åvall-Lundqvist, E., Pfisterer, J., and Bacon, M., The Gynecologic Cancer Intergroup (GCIG): history and current status., Ann Oncol, vol. 16 Suppl 8, pp. viii39-viii42, 2005.